about
Antidepressants for depression in physically ill peoplePhysical measures for treating depression in dialysis patientsAntidepressants for treating depression in adults with end-stage kidney disease treated with dialysisMedication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis providerDepression in dialysis patients.A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease.The effects of antidepressant treatment on serum cytokines and nutritional status in hemodialysis patients.Associations of depressive symptoms and pain with dialysis adherence, health resource utilization, and mortality in patients receiving chronic hemodialysisOral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, lLongitudinal associations of depressive symptoms and pain with quality of life in patients receiving chronic hemodialysis.Epidemiology, diagnosis, and management of depression in patients with CKD.A study of sertraline in dialysis (ASSertID): a protocol for a pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysis.Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND)Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: Frequent Hemodialysis Network (FHN) Trials.Comparison of symptom management strategies for pain, erectile dysfunction, and depression in patients receiving chronic hemodialysis: a cluster randomized effectiveness trial.Impact of combined treatment with rosuvastatin and antidepressants on liver and kidney function in ratsConsequences of CKD on Functioning.Psychosocial intervention improves depression, quality of life, and fluid adherence in hemodialysis.Dying on dialysis: the case for a dignified withdrawal.Fatigue in chronic dialysis patients.Psychological distress and depression in patients with chronic kidney disease.Depression and chronic kidney disease: A review for clinicians.Psychotherapeutic Agents in End-Stage Renal Disease.Patient-Centered Dialysis Care: Depression, Pain, and Quality of Life.How Can We Improve the Quality of Life of Dialysis Patients?Acceptance of Antidepressant Treatment by Patients on Hemodialysis and Their Renal Providers.The Impact of Multidisciplinary Rehabilitation on Depressive Symptoms in Hemodialysis Patients.Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility Trial.SELF-REPORTED MEDICATION ADHERENCE IN PATIENTS WITH END-STAGE KIDNEY DISEASE UNDERGOING ONLINE-HAEMODIAFILTRATION.Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.Depression in Chronic Kidney Disease and End-Stage Renal Disease: Similarities and Differences in Diagnosis, Epidemiology, and Management.Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need.Correlation of antidepressive agents and the mortality of end-stage renal disease.
P2860
Q24236616-77F0D5FD-28C9-4DF3-B070-51506C2CFD63Q24244095-E7258930-0B0E-45B7-BF83-B32C8EE499D7Q26471942-6431C7DC-613E-4058-966A-F0F370B77A27Q28168531-7B20A4A6-9306-47D9-8EB9-F9F85917B493Q30251916-D5D79CC9-AFDC-44B2-AF50-BB11B5E09055Q30408395-CEB848AF-90AF-451D-B9D5-142E02480826Q33631552-6B6D934C-D6A1-4A56-B6BF-D023119513B0Q34124691-ED36BC16-EBCF-4CC0-A25E-1DC8DCBF75D0Q34676710-88D60B10-F39E-4C5E-B414-FDC1FAAF7CE0Q35251827-55D39E6F-2C82-4C87-94B1-02485CE6D150Q35553004-865755B2-9A4D-4984-AFD6-359B5C751B3DQ35821850-BD67B6F2-B0EF-40D5-BF0F-27B3419A2D27Q35856417-6CD52C6C-64B4-4DC5-BC67-B14B3A9C7241Q36003318-2C7E5FBD-5926-438D-B99F-9980F56E9107Q36492547-82FEE8F9-C279-46F7-851C-D7ADD3B1F4F9Q36741741-FB4E3322-7539-41E4-82E9-2DC5990C1D19Q37141165-63023A67-1F43-4968-9A4F-89416DD03E3FQ37411626-947A9277-88A6-4B40-A7A1-BDE6FFFA65C2Q37426974-907761EA-7BE1-4085-86F9-A682903D9414Q37932045-E47B457F-0A37-4163-812C-21D8CD58A711Q38027185-3CEF8F9A-9812-4B20-8C5F-EB50900514BAQ38198493-55D2B9AE-6BDC-4D5B-977B-CCA35E1E57B2Q38413315-D5ABDA94-9AEE-41D6-8349-8A3D73F8DEC2Q38691199-BB4C92B6-E95A-4756-9BB5-FFB44746AD73Q38693389-353D8971-FAD3-4590-B6EB-3B1E734D019BQ38765349-665E2D51-464C-4C4D-B361-62F2433C410AQ38891237-AB02FE4C-D0FB-4F90-860B-E7688317E3B5Q38996603-91B0FCB9-202E-4A8B-9135-A0685243ADA1Q40106865-5ED07E47-70D5-4A91-A576-4AFAA227EB55Q47160609-73A7AABB-60DA-44EB-AC3F-A7DF216290AAQ48040943-6D3D2D31-EB89-43F3-8314-E9D7874CA9B7Q48224940-F14DA2D8-EDA3-4AB8-82B4-17F07EDB90B6Q48750587-519557EA-EB96-4B41-AD0F-D8FB1448D3A4
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Fluoxetine in depressed patients on dialysis.
@en
Fluoxetine in depressed patients on dialysis.
@nl
type
label
Fluoxetine in depressed patients on dialysis.
@en
Fluoxetine in depressed patients on dialysis.
@nl
prefLabel
Fluoxetine in depressed patients on dialysis.
@en
Fluoxetine in depressed patients on dialysis.
@nl
P2093
P2860
P1476
Fluoxetine in depressed patients on dialysis.
@en
P2093
B Spinowitz
C Charytan
C M Beasley
M Blumenfield
R F Bergstrom
R J Solomon
P2860
P356
10.2190/WQ33-M54T-XN7L-V8MX
P577
1997-01-01T00:00:00Z